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Nuclear receptors (NRs) are transcription factors that regulate gene expression in response 
to small signaling molecules. The NR family includes receptors for thyroid hormone (TH) 
(Yen, 2001), retinoids, vitamin D, steroid hormones, fatty acids, bile acids and cholesterol 
derivatives, a variety of xenobiotics and other ligands. Additionally, other members are 
called orphans and could either bind to ligands that have not yet been identified or 
modulate gene expression in a ligand independent fashion (Webb et al., 2002). 
Since NR play important roles in development and disease, they are important candidates 
for pharmaceuticals. This family of proteins can be modulated by natural and synthetic 
ligands and are therefore promising targets for drug discovery. The natural ligands may 
include different kinds of plant molecules or even a combination of compounds present in 
raw extracts of medicinal plants.  
1.1 Compounds that bind NR 
Ligands that target NRs include TH, glucocorticoids, estrogens for hormone replacement 
therapy (HRT), the diabetes drug thiazolidinedione, synthetic retinoids, and many others. 
Though the list of possible targets is extensive, it is restricted by the fact that NR ligands 
have both beneficial and deleterious effects. For instance, TH improves overall lipid balance 
and promotes weight loss by increasing metabolism, but causes tachycardia that can be 
severe enough to lead to heart failure, muscle wasting and osteoporosis (Felig & Baxter, 
1995; Braverman et al. 2000). Likewise, estrogen use in HRT alleviates symptoms of hot 
flashes and reverses bone loss, but increases the risk of breast and uterine cancers, and 
stroke (Gustafsson, 1998; McKenna & O´Mally, 2000; McDonnel & Norris, 2002). 
1.2 Thyroid hormone receptor (TR) isoforms 
Thyroid hormone signals are transduced by two related thyroid receptor subtypes, TR ǂ and 
TR ǃ (Figure 01.) which are encoded by different genes (Gauthier et al., 1999). 
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Thyroxine Triiodothyronine  
Fig. 1. Chemical structures of thyroid hormones thyroxine (ǂ) and triiodothyronine (ǃ). 
Studies of TR isoform-specific knockout mice and patients with resistance to thyroid 
hormone syndrome suggest that TR ǂ mediates the effects of thyroid hormone on heart rate, 
whereas analogs that exclusively stimulate TR beta might have desirable effects without 
causing cardiac distress. Indeed, animal studies using thyroid receptor agonists with modest 
TR beta selectivity have validated this hypothesis (Taylor et al. 1997; Baxter et al., 2001; 
Grover et al., 2003). However, structure-based approaches to develop ligands with further 
improvements in isoform specificity are limited by the fact that the LBDs of TR alfa and TR 
beta are ~75% identical in amino acid sequence, and that the internal hydrophobic cavities 
that hold the hormone, called the pocket of the receptor, differ by just one amino acid (Ser-
277 in TR alfa versus Asn-331 in TR beta). Therefore, it would be interesting to develop 
selective TR agonists that increase metabolism and improve lipid balance, but do not cause 
side effects on the heart. The first compound to show this property was GC-1 (Figure 02), an 
analog of T3 (Chiellini et al., 2002). 
GC-1
 
Fig. 2. Chemical structure of the ǃ-specific thyroid hormone receptor agonist GC1. 
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2. TR antagonists 
2.1 First generation of synthetic ligands 
TR antagonists would be useful for short-term relief from the symptoms of 
hyperthyroidism, and might even be used on a long term basis. The first generation of T3 
antagonists, which include DIBRT, HY-4, and GC-14, used the “extension hypothesis” as a 
general guideline in hormone antagonist design (Baxter et al., 2002; Yashihara et al., 2001; 
Chiellini et al., 2002). This extension in the ligand structure blocks normal receptor function 
by occupying the pocket region where the hormone normally binds.  
Thyroid hormone receptor antagonist DIBRT 
Fig. 3. Chemical structure of thyroid hormone receptor antagonist DIBRT. 
2.2 Novel series of antagonist compounds 
Although the “extension hypothesis” is applicable to the design of nuclear receptor 
antagonists, the nature of chemical groups that convert agonist ligands to antagonists will 
likely depend on specific interactions between residues of the receptor and the ligand 
extension, to help stabilize the antagonist conformation. Following the first designed TR 
antagonists it was reported the design and synthesis of a novel series of compounds sharing 
the GC-1 halogen-free thyronine scaffold (second generation). One of them (NH-3) is a T3 
antagonist with improved TR binding affinity and potency that allow for further 
characterization of its observed activity. One mechanism for antagonism appears to be the 
ability of NH-3 to block TR-coactivator interactions (Ngoc-Ha et al., 2002). NH-3 (Figure 04.) 
is the first T3 antagonist to exhibit potent antagonism in vivo and therefore may prove to be 
a generally useful tool for studying the effects of TR inactivation in a variety of animal 
models. Until now, such studies have been done primarily using TR-knockout mice because 
a pharmacological tool for inducing TR inactivation has not been available. TR inactivation 
was limited under previous ligands because they have only a modest affinity and potency 
for the thyroid hormone receptor (TR), which limits studies of their actions. T3 antagonists 
such as NH-3 may be useful therapeutic agents in the treatment of hyperthyroidism and 
other metabolic disorders. 
3. Plant ligands of nuclear receptors 
3.1 Estrogen analogs 
Although modern research on drug discovery involves the design of hormone analogs based 
on the structure of the receptor, natural ligands can also be found in nature. Estrogen analogs 
are most common and have been discovered in a variety of plants. Ginsenosides (Figure 05.) 
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for instance, found in Ginko biloba, have demonstrated pharmacological effects on the central 
nervous, cardiovascular, and endocrine systems. Although no direct interaction of the 
compound with estrogen receptor seems to be necessary for estrogenic action, the author 
classified this plant ligand as a novel class of potent phytoestrogen (Chan et al., 2002). 
NH-3  
Fig. 4. Chemical structure of the thyroid hormone receptor antagonist NH-3 (Lim et al. 
2002), designed by the extension hypothesis from GC-1 compound. 
Ginsenoside  
Fig. 5. Chemical structure of a ginsenoside. 
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Recently, Tephrosia candida (native to the tropical foothills of the Himalayas in India and 
introduced in South America) was reported to contain estrogenically active chemical 
constituents, which acted by binding to estrogen receptor ERǂ. Results were interpreted via 
virtual docking of isolated compounds to an ERǂ crystal structure (Hegazy et al., 2011). Also 
sesame ligands, from Sesamum indicum (flowering plant, native to Africa and widely 
naturalized in tropical regions around the world), and their metabolites have been evaluated 
for estrogenic activities (Pianjing et al., 2011). Two of them, enterodiol (Figure 06.) and 
enterolactone, have been indicated to have estrogenic/antiestrogenic properties on human 
breast cancer cells. 
Enterodiol  
Fig. 6. Chemical structure of an enterodiol 
3.2 Androgen analogs 
As compared to estrogen analogs, androgen-like compounds in the flora are less frequently 
referred in scientific literature. But a few chemicals have shown androgen-like activity. 
Andrographolide (Figure 07.), an herbal medicine, inhibits interleukin-6 expression and 
suppresses prostate cancer cell growth (Chun et al., 2010). According to the author, this 
phytochemical could be developed as a therapeutic agent to treat both androgen-stimulated 
and castration-resistant prostate cancer. Another compound, Isoangustone A, present in 
hexane/ethanol extract of Glycyrrhiza uralensis, induces apoptosis in DU145 human prostate 
cancer (Seon et al., 2010). This species, also known as Chinese liquorice, is a flowering plant 
native to Asia, which is used in traditional Chinese medicine. 
3.2.1 Androgen ligands in the diet 
Some studies have specifically demonstrated that consuming one or more portions of 
broccoli per week can reduce the incidence of prostate cancer, and also induce the 
progression from localized to aggressive forms of prostate cancer (Trakka, et al. 2008). The 
reduction in risk may be modulated by glutathione S-transferase mu 1 (GSTM1) genotype, 
with individuals who possess at least one GSTM1 allele (i.e. approximately 50% of the 
population) gaining more benefit than those who have a homozygous deletion of GSTM1, 
according to the author. 
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Fig. 7. Chemical structure of an andrographolide. 
From these studies, we can conclude that diet has a significant influence on the activity of 
the androgen receptors and possibly other types of nuclear receptor. If so, a wide range of 
diseases may be avoided by increasing intake of food that contains hormone analogs or 
other nuclear receptor modulators.  
3.3 Plant thyroid hormone analogs 
Concerning the thyroid hormone receptor, we find even fewer studies about thyroid 
hormone (T3 and T4) analogs in plants. In a work about patients where thyroid have been 
removed partially or totally due to thyroid cancer, the plant R. rosea was seen as a viable 
alternative treatment for the symptoms of short-term hypothyroidism in patients who 
require hormone withdrawal (Zubeldia et al., 2010). Some compounds of natural origin 
have also shown to affect the thyroid hormone feedback system by interfering with 
different components of this homeostatically regulated system: biosynthesis, secretion and 
metabolism, transport, distribution, and action of thyroid hormones, including the 
feedback mechanism. 
Genistein (Figure 07.) and daidzein, the major components of soy, influence thyroid 
hormone synthesis by inhibition of the iodide oxidizing enzyme thyroperoxidase. This 
interferes with thyroid hormone transport proteins and 5′-deiodinase type I activities in 
peripheral tissues, leading to altered thyroid hormone action at the cellular level. Synthetic 
flavonoids, such as F21388, which is structurally similar to thyroxine, cross the placenta and 
also reach the fetal brain of animal models (Hamann et al. 2008). 
The cruciferous family was also referred when we consider thyroid modulators in plant. In a 
study that examined the effects of both soy-foods and specific phytoestrogenic molecules 
on the development of thyroid cancer in humans it was demonstrated that intake of plants 
from that family decreases the risk of this kind of cancer (Horn-Ross et al., 2002). The 
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compounds that may be associated with this effect are, according to the author, 
isoflavones, lignans and 2-hydroxyestrogens. Although anti-carcinogenic response was 
linked to those molecules, it was not explained how they may affect metabolism in 
humans or their physiological mechanism of action. Another compound, indole-3-
carbinol, the most studied component of cruciferous vegetables, has been demonstrated to 
have chemopreventive activity in several different animal models of carcinogenesis, 
including mammary gland, but in another hand, the same compound has also been 
reported to exhibit adverse promoting effects, including liver and thyroid gland 
tumorigenesis (Murilo & Mehta, 2001). 
Genistein  
Fig. 8. Chemical structure of a Genistein. 
It seems to have a cross talk between the thyroid hormone receptor and the estrogen 
receptor. Our recent results (Cunha Lima et al, not published) have shown that ligands 
originally referred for thyroid diseases have activated estrogen receptor in transient 
transfection assays. This could explain why phytoestrogens have caused responses in 
thyroid cancer and thyroid hormone analogs have also effect in breast cancer, for 
example. 
3.4 Toxicity of thyroid hormone analogs 
Considering medications used for thyroid hormone replacement, as sodic levothyroxine, 
aT4 analog, the side effects referred (Cunha Lima , 2008) may include headache, chest 
pain, rapid or irregular heartbeat, shortness of breath, trembling, sweating, diarrhea and 
weight loss. The most severe responses are those related to the heart, which can lead to 
serious cardiopathies and are due to the ǂ isoform of the receptor, as cited previously. A 
single base difference in the pocket of the protein can lead to these harmful responses. 
This means that we have a two step work on the search for new agonists and antagonists: 
they should mimesis the response caused by the thyroid hormone (or antagonize it, 
depending on the disease) and second, they should have a ǃ specificity to avoid 
tachycardia and more serious heart problems. 
In the other hand, some compounds that modulate TR may not be specific for this 
receptor, as it is very common with estrogen ligands. Since women hormone analogs may 
interfere with the function of the thyroid, as referred before with some flavonoids, they 
may have beneficial effects in cases of thyroid cancer. Nevertheless those compounds may 
influence thyroid actions at the cellular level and could cause side effects harmful for 
healthy individuals.  
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3.5 Ethnobotanical search for TR plant ligands 
Since thyroid hormone analogs have much fewer discovered natural ligands, and most of 
those nuclear receptor ligands are found from plant sources, ethnobotanical surveys can be a 
good strategy to discover hormone analogs in nature. This approach has an increased 
probability of success in locations with higher biodiversity; because they contain a 
privileged number of candidate species. Along with botanical diversity, ethnobotanical 
surveys are likely to succeed where the population has an in depth knowledge of medicinal 
plants and systematically uses those plants to treat a range of metabolic disorders.  
In a recent work (Cunha Lima et al., 2008) we investigated the medicinal flora used for the 
treatment of metabolic disorders in Salvador, Bahia, in Northeastern Brazil. The city has 
hot, tropical weather, with average daily highs reaching 170C in the winter and 380C in the 
summer. Northeastern Brazil is the economically poorest region of the country, 60% of the 
active population has an income under $100 per month, (Brazilian Institute of Statistics 
and Geography, 2003) and many residents depend on medicinal plants to treat multiple 
ailments and diseases.  
The referred study analyzed the knowledge of the urban population of Bahia city on the 
use of potentially therapeutic plants for the treatment of Diabetes mellitus type 2 (DM2), 
thyroid diseases, obesity and cardiopathies. Questionnaires were applied to traditional 
healers as well as to patients of the thyroid disease and diabetes ambulatory in the 
Hospital from Federal University of Bahia (UFBA). Thirty-one cited species were 
collected, taxonomically classified, and stored in Alexandre Leal Costa Herbarium (ALCB) 
from UFBA. Leaves were most commonly used in preparations (87%), followed by the 
whole plant (10%), and fruits and seeds (3%). The majority of the preparation (88%) 
required decoction (boiling the plant tea for at least 5 minutes); the rest includes infusion 
(liquid preparation without boiling) and ingestion of the fresh plant. Among the plant 
parts used the leaves were more frequent (87%), followed by the whole plant (10%), seeds 
and fruits (3%). The families Asteraceae (17%), Lamiaceae (15%) and Myrtaceae (12%) 
were the most cited among plants referred.  
This survey identified botanical families frequently cited in other surveys of medicinal plant 
use in Brazil. In two studies conducted in the state of Rio de Janeiro, one in Rio city 
(Azevedo & Silva) and one in the reservation of Mangaratiba (Medeiros et al., 2005), the 
Asteraceae and Lamiaceae family of plants were the most frequently cited, the same 
happening in Conceição Açú-MT (Pasa et al., 2005). Species from the Asteraceae family were 
also the most frequently noted for medicinal use in a survey done in Ingaí-MG (Botrel et al., 
2006) and by a “quilombola”(community of people descended from former Brazilian slaves), 
among the plants with possible action in the central nervous system (Rodrigues & Carlini, 
2004). These data suggest that the Asteraceae and Lamiaceae family have excellent 
pharmacological potential on different kinds of diseases and they are currently being 
investigate in many clinical studies. 
In the survey performed by our group in Salvador (Cunha Lima, 2008), the plant most used 
for the treatment of DM2 belongs to the genus Bauhinia (pata-de-vaca). The most commonly 
cited species in this work, B. forficate, has the flavonoid Kaempferitrina, Kaempferol-3-O-ǂ-
Diraminoside and the steroid Sitosterol as the hypoglycemic active principle (da Silva & 
Cechinel Filho, 2002). Terminalia catappa was the second most cited species for the treatment 
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of DM2. Ahmed et al. (2005) demonstrated that the extract from this plant also has 
hypoglycemic activity and improves general clinical conditions. 
Among the plants used for obesity control, with probable effect on the metabolism, Borreria 
verticillata (carqueija or vassorinha-de-botão) was the species with the highest number of 
references in our survey. This plant, also used for the treatment of diabetes type 2, is found 
across Brazil. Phytochemical studies have demonstrated the presence of alcaloids and 
iridoids (Vieira et al., 1999) associated with their antipyretic and analgesic properties, 
although no active principle linked to obesity was confirmed. The leaves of Bauhinia forficata, 
Costus spiralis and Theobroma cacao, were used as teas in combination with the commercial 
medical prescriptions sibutramine (an oral anorexiant used for weight control) and 
niphedipine (a dihydropyridine calcium channel blocker used for high blood pressure) 
indicated by the physicians from the Diabetes Ambulatory of the Federal University of 
Bahia Hospital (HUPES). The teas of Tragia volubilis leaves and the seeds of Ocimum 
gratissimum were also used in combination with niphedipine and aspirin.  
The problems related to the thyroid attended at the Hospital of Federal University of Bahia 
include throat itch, tachycardia, arm pain, chokings, dizziness and fainting. The most 
extreme side effects symptoms are associated with the T4 hormone replacement for patients 
whose thyroid was partially or completely removed. The doses used vary from 50 to 
200mcg/day of sodic levotiroxine. In addition to the plants cited for treatment of thyroid 
problems, watercress (Nasturtium officinale R.Br.) and spring-green (Brassica oleraceae L.) were 
eaten as iodine source. Although the majority of the patients did not tell their doctors they 
were using those teas, there are no reported adverse side effects due to the combination of 
the plant products and the medications indicated, nor any reference in the literature about 
harmful effect of such interaction.  
Ethnobotanical surveys are good source of information for drug candidates and offer a less 
expensive way of finding hormone analogs than the design of synthetic compounds. The 
cited information represents an important source of regional knowledge on plants with 
pharmacological potential and presents 31 candidates (Table 1) that might contain 
triiodothyronine (T3) and thyroxin (T4) analogs, including agonists, antagonists and other 
compounds able to modulate thyroid receptor that may act against metabolic disorders.  
Brazil has more than 55.000 species of cataloged plants (Simões & Schenkel, 2002), a 
significant portion of which has some phytotherapic activity known by the local population. 
However, the number of patents on plant-based pharmaceuticals is very small. In particular, 
the capital of Bahia has numerous plants used by inhabitants to treat diseases and this use is 
part of the local culture, based in the Candomblé (religion of African origin which uses 
many plants in rituals and treatments). Traditionally, information about medicinal plants is 
shared orally. Therefore, it is necessary to scientifically systematize and analyze this 
phytotherapic knowledge so that those species can be identified and their pharmacological 
properties tested. 
Table 2 lists the species referred in this survey that had their active principles identified 
and/or properties confirmed, and the bibliographic references where the data was obtained. 
These works include results from clinical and experimental studies aiming the confirmation 
of therapeutic properties.  
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Vernacular Name ALCB Family Species 
1. aroeira 76103 Anacardiaceae Schinus terebinthifolius Raddi 
2. graviola 76101 Annonaceae Annona muricata L. 
3. jaca-de-pobre 76154 Annonaceae Annona montana Macfad 
4. carrapixo-de-agulha 76135 Asteraceae Bidens bipinnata L. 
5. carrapixo-preto 76111 Asteraceae Bidens pilosa L. 
6. chapéu-de-couro 76138 Asteraceae Zinnia elegans Jacq. 
7. urucum 76100 Bixaceae Bixa orellana L. 
8. cactus 78152 Cactaceae Cereus sp. L. 
9. pata-de-vaca 76159 Caesalpiniaceae Bauhinia forficata Link 
10. amendoeira 76096 Combretaceae Terminalia catappa L. 
11. cana-de-macaco 76122 Costaceae Costus spiralis (Jacq,) Roscoe 
12. mamona 76141 Euphorbiaceae Ricinus communis (L.) Müll. Arg. 
13. urtiga 76108 Euphorbiaceae Tragia volubilis (L.) Müll. Arg. 
14. alecrim ou alecrim-do-
reino 
76128 Lamiaceae Rosmarinus officinalis L. 
15. hortelã-grosso 76110 Lamiaceae 
Plectranthus amboinicus (Lour.) 
Spreng 
16. quiôiô 76112 Lamiaceae Ocimum gratissimum L. 
17. canela 76099 Lauraceae Cinnamomum zeylanicum Breyn 
18. erva-de-passarinho 76107 Loranthaceae Struthanthus flexicaulis Mart. 
19. Murici 78150 Malpighiaceae Byrsonima sericea DC. 
20. barbatimão 76158 Leguminosae 
Abarema cochliocarpum (Gomez) 
Barnbey 
21. jamelão 76156 Myrtaceae Syzygium cumini (L.) Skeels 
22. pitangueira 76163 Myrtaceae Eugenia uniflora L. 
23. capim- cidreira ou capim-
santo 
75150 Poaceae Cymbopogon citratus Stapf. 
24. roma 76162 Punicaceae Punica granatum L. 
25. carqueija ou vassourinha-
de-botão 
76132 Rubiaceae Borreria verticillata (l.) G.Mey 
26. laranjeira 76097 Rutaceae Citrus aurantium L. 
27. vassourinha 76114 Scrophulariacea Scoparia dulcis L. 
28. cacau 78148 Sterculiaceae Theobroma cacao L. 
29. erva cidreira 76105 Verbenaceae Lippia alba N.E.Brown 
30. melissa 76120 Verbenaceae Lippia alba L.. 
31. levante 76123 Zingiberaceae Alpinia nutans Roscoe 
Table 1. Medicinal plants candidates for thyroid hormone analogs according to 
ethnobotanical research in Salvador-Bahia, Brazil (Cunha Lima, 2008). 
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Species Properties associated to the referred use Reference 
Bauhinia 
forficata 
The flavonoids Kaempferitrin and Kaempferol-3-
O--Diraminoside and the steroid Sitosterol found 
in the extract own hypoglycemic properties. 




Leaf extract prepared in different ways produced 
antidiabetic response with 1/5 of the lethal dose 
revealed by the lipid, creatine and urea profile as 
also serum alkaline phosphatase. The same dose 
caused anti-diabetic effects with fruit extracts. 
Ahmed et al (2005) 
 
 




The anti-oxidants impair the mechanism of 
oxidation that occurs in cancer, heart disease , 
atherosclerosis and aging. 
Ibanez et al (2000) 
Cymbopogon 
citratus 
Intense anti-oxidant activity due to the phenolic 
composition. The essential oil extracted from the 
leaf causes depression of the CNS in rats. 
Prakash et al (2007);  
Negrelle (2007) 
Bidens pilosa 
Deposits of opaline silica in the leaves and extracts 
of the whole plant obtained with n- hexane 
demonstrated significant anti-cancer activity.  
Parry (1986); 
Sundararajan et al 
(2006) 
Lippia alba 
Flavonoids found in this plant are active against 
different kinds of cancer including thyroid 
cancers.  
Ren et al (2003) 
Annona 
muricata 
Graviola, a Brazilian fruit from the plant Annona 
muricata demonstrated anti-diabetic effect greater 
than the medication Clorpropamide, oral 




The plant has kinase protein inhibitors that act 
creating obesity resistance and increasing insulin 
production. 
Bialy et al (2005) 
Syzygium 
cumini 
The species presents anti-diabetic action in clinical 
and animal studies. Stem extracts stimulate the 
development of cells positive for insulin in the 
pancreatic epithelial duct.  
Mentreddy (2007); 
Teixeira et al (2004); 




The combination of C. aurantium extract, caffeine 
and Saint John´s Herb (Hypericum perforatum) is 
safe and effective for weight lost and 
improvement of lipid levels in obese adults.  
Colker et al (1999) 
Alpinia 
nutans 
The hidroalcoolic extract induces a dose-
dependent decrease in artery pressure in rats and 
dogs.  
Mendonça et al 
(1991) 
Lippia alba 
The aqueous extract of leaves from this plant, 
associated to the ones from Melissa officinalis and 
Cymbopogon citratus caused significant reduction 
in cardiac rhythm in rats, without changing the 
contractile strength.  
Gazola et al (2004) 
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Species Properties associated to the referred use Reference 
Bauhinia 
forficata 
The rats treated with decoction of the plant leaves 
demonstrated significant reduction in serum and 
urine glucose. The results obtained with the 
purified extracts confirmed the therapeutic use for 
treatment of diabetes in clinical studies. 
Pepato et al (2002); 




The empiric use of this plant is due to the 
hypotensive effect, mediated by vessel dilatation 
and weak diuretic effect that may be related to 
increased renal blood flow.  




Flavonoid rich fractions obtained from fruit 
extracts demonstrated antiperoxidative effect. 
Malondialdehyde, hydroperoxide, and conjugated 
dienes were significantly decreased in the liver, 
while enzymatic activity of catalase, superoxide 
dismutase and glutathione reductase have shown 




Plant extracts were effective on decreasing 
hyperglycemia and the susceptibility to free 
oxygen radicals in rats.  
Latha & Pari (2004) 
Table 2. Plant species referred in the survey that have their therapeutic properties confirmed 
or active principles isolated according to scientific publications. 
4. Conclusion 
Studying medicinal plants can be a less expensive way of finding treatments for hundreds of 
diseases. This can be an important factor in areas where a great part of the population lacks 
financial conditions of buying allopathic medication and, in the other hand, have a big 
incidence of metabolic disorders. 
The search for hormone analogs in medicinal plants is extremely promising. Over 100 
existing nuclear receptors have been identified, not counting the orphan NRs that lack 
known ligands. Since those transcription factors modulate almost all genetic activity and 
human physiology, they are important targets for drug discovery. Besides the ligands, 
usually hormones, other molecules can also modulate nuclear receptors, including cofactors 
(co-activators and co-repressors), responsive elements, and other ligands (not exclusively 
the hormone that naturally binds this receptor). According to that, the molecules found in 
plants do not have to be only analogs of hormones, but also compounds similar to all other 
complementary modulators of NRs. 
Countries with higher biodiversity are good targets for discovery of plant molecules that 
can control the activity of thyroid receptor. Unfortunately there is not enough scientific 
knowledge about their medicinal plants or about patent procedures that would guarantee 
intellectual property of discoveries made by local scientists. In addition to that, the forests 
are being devastated very fast before important plant compounds can be found. 
Therefore, additional research needs to be done to identify new ligands and other 
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molecules in the flora that can modulate TR and may be used in the treatment of diseases 
related to thyroid malfunction. 
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